Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
April 24, 2018
ADMA Biologics Announces the Release of its First Commercial Batch of Nabi-HB Manufactured Under its Ownership
RAMSEY, N.J. and BOCA RATON, Fla., April 24, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), today announced that it has ...
April 24, 2018
ESSA Pharma Enhances R&D Capabilities with Two New Key Hires
HOUSTON and VANCOUVER , April 24, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX, TSX-V: EPI), a pharmaceutical company focused on ...
April 24, 2018
PolarityTE Announces Appointment of McKesson’s Willie Bogan to Board of Directors
SALT LAKE CITY, April 24, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of ...
April 20, 2018
Theravance Biopharma Highlights Landmark IMPACT Study Published in NEJM Showing Significant Benefits of Trelegy Ellipta for COPD Patients
DUBLIN, April 19, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma") today highlighted the publication in the New England Journal of Medicine (NEJM) of the ...
April 20, 2018
ESSA Pharma Inc. Announces Share Consolidation
HOUSTON and VANCOUVER , April 19, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pre-clinical stage pharmaceutical company ...
April 20, 2018
Basilea reports presentations of isavuconazole and ceftobiprole data at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Basel, Switzerland, April 20, 2018 - Basilea Pharmaceutica Ltd. (SIX:BSLN) announced today that a broad range of posters and presentations on the antifungal isavuconazole (Cresemba®) ...
April 20, 2018
Arcturus Therapeutics Files Lawsuit Against Joseph E. Payne and His Associates for Violations of Federal Securities Laws
SAN DIEGO, April 20, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, initiated a lawsuit in the United States District Court for ...
April 19, 2018
Pfenex and NT Pharma Enter into a Development and License Agreement for Pfenex's PF708 Therapeutic Equivalent Candidate to Forteo®
SAN DIEGO and HONG KONG, April 18, 2018 /PRNewswire/ -- Pfenex Inc. (NYSE AMERICAN: PFNX) and China NT Pharma Group Company Limited (NT Pharma) (1011.HK) today ...
April 19, 2018
Aeglea BioTherapeutics Prices Public Offering of Common Stock
AUSTIN, Texas, April 18, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (AGLE) a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
April 19, 2018
Management Change in Moberg Pharma
STOCKHOLM, April 19th, 2018 /PRNewswire/ --Moberg Pharma AB (OMX:MOB) announces that Kjell Rensfeldt, VP Research and Development, will retire in the fall but remain with ...
April 19, 2018
iCAD Announces Presentation of Positive Clinical Data on Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers at ESTRO 37
NASHUA, N.H. and BARCELONA, Spain, April 19, 2018 (GLOBE NEWSWIRE) -- ESTRO Booth 6800 -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative ...
April 19, 2018
VBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B Vaccine
CAMBRIDGE, Mass., April 19, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (VBIV) (“VBI”) today announced the completion of enrollment with the last patient receiving the ...
April 19, 2018
Albireo to Present Data from Two Studies on Cholestatic Liver Disease at the 51st ESPGHAN Annual Meeting
BOSTON, April 19, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today ...
April 19, 2018
Krystal Biotech Presents Their Skin TARgeted Delivery Platform at the World Orphan Drug Congress USA
PITTSBURGH, April 18, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., ("Krystal") (NASDAQ:KRYS), a gene therapy company developing "off-the-shelf" treatments for rare dermatological diseases, today announces ...
April 19, 2018
Krystal Biotech’s KB103 Receives Orphan Medicinal Product Designation in Europe for Dystrophic Epidermolysis Bullosa
PITTSBURGH, April 19, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (“Krystal”) (KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients ...
April 19, 2018
Paratek Pharmaceuticals, Inc. Prices $140 Million of Convertible Senior Subordinated Notes due 2024
BOSTON, April 19, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
April 19, 2018
Keryx Biopharmaceuticals Announces Late-breaking Ferric Citrate Abstract Accepted for Presentation at the 55th ERA-EDTA Congress
BOSTON, April 19, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today ...
April 16, 2018
Albireo Reports Data on Pharmacodynamic Marker for A4250 in Children with Cholestatic Liver Disease at The International Liver Congress™ 2018
BOSTON, April 14, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced that ...
April 16, 2018
Lysogene Reports First Quarter Financial Results and Provides Business Update
CAMBRIDGE, Mass. and PARIS, April 16, 2018 (GLOBE NEWSWIRE) -- Lysogene (FR0013233475 – LYS), a leading biopharmaceutical company pioneering gene therapy technologies to treat central ...
April 16, 2018
Biom'up reports 2017 full-year results and provides corporate update
SAINT-PRIEST, France, April 16, 2018 (GLOBE NEWSWIRE) -- Biom'up (the "Company"), a specialist in surgical hemostasis, today announced its 2017 full-year results, as approved by ...
Page 49 of 117